From Petri Dishes to Quantum Proteins

Gemini Generated Image

I’ve written here a bit about my undergrad degree in microbiology, The path to that degree came with a strong dose of biochemistry along the way. UMass Amherst, mid-1970s. I worked through enzyme kinetics, the Michaelis-Menten equation, and the standard biochem textbook of the day, Lehninger's Biochemistry. Then I spent a few years in a hospital clinical lab, plating cultures and squinting at gram stains, before I shifted into electrical engineering. The proteins we now talk about in quantum computing papers were, back then, things you drew mechanisms for on an exam and tried not to confuse.

When I saw the May 19 Phys.org piece on a 12,635-atom protein simulation, the old biochem brain lit up. Cleveland Clinic, RIKEN, and IBM used a quantum-centric supercomputing workflow to model two real proteins, T4-Lysozyme and Trypsin, sitting in water with the small molecules they bind to. Trypsin is a serine protease from your pancreas. It cuts other proteins at specific spots, after the amino acids lysine and arginine. T4-Lysozyme is an enzyme that breaks down peptidoglycan, the mesh that holds bacterial cell walls together. Both are fundamental biochem topics.

So.... what does "simulate a protein" mean? A protein is a folded chain of atoms. It does its job because of its shape and because of how the electrons inside it are arranged. Simulating it means using physics to figure out where every electron is and how it is moving. That information is what tells you whether a drug molecule will fit into the protein and stick, or just bounce off. The bigger the protein, the harder that calculation gets, and the difficulty grows fast.

Six months earlier, the same team did a 303-atom Trp-cage, a tiny model protein biochemists use as a folding test case. This run jumped to 12,635 atoms. That is a 40-fold increase in size and a 210-fold gain in accuracy on a key step. The hardware was IBM's 156-qubit Heron r2 quantum processors at Cleveland Clinic and RIKEN, working alongside Fugaku and Miyabi-G, two of the largest classical supercomputers in Japan. The team ran the quantum machines for more than 100 hours and collected 1.3 billion measurements.

So why is quantum better here? Think about it this way. Electrons in a molecule don't sit still like marbles. They behave like little waves that overlap and influence each other. To keep track of just one electron on a regular computer, you need to store some numbers describing its wave. Add a second electron that interacts with the first, and you don't double the work, you square it. Add a third, you cube it. The work doubles with every electron you add. Ten electrons is easy. Fifty electrons fills up a big supercomputer. A hundred electrons would need more memory than there are atoms in the Earth. A protein has thousands.

A quantum computer is built out of the same kind of stuff the electrons are made of. Each qubit is itself a tiny quantum object that can hold the wave behavior directly. So instead of storing a giant list of numbers to fake the physics, the qubits just do the physics. Fifty electrons need about fifty qubits, not a supercomputer. One hundred electrons need about one hundred qubits. The problem stops blowing up. Richard Feynman pointed this out in 1981: if you want to simulate nature, use a computer made of the same stuff as nature.

Back to classical computers for a moment. There is a method that gets the right answer exactly, called full configuration interaction. It is the gold standard. The problem is that every electron you add doubles the work, which is exactly the blowup I just described. It works fine for a water molecule. It is impossible for a protein.

So computational chemists fake it. They use an approximation called density functional theory, or DFT, which gives a fast, decent answer for most of a molecule. DFT is the workhorse of computational biochemistry today. It has a known weak spot, though. It struggles in the active site of an enzyme, the small pocket where the actual chemistry happens and where a drug would bind. That is the one place you need the answer to be right, and it is the one place DFT gets shaky.

That is where the hybrid setup comes in. Use the quantum computer on the small, tricky pocket where DFT fails. Use the classical supercomputer on the rest of the protein and the surrounding water, where DFT works fine. Each machine does the part it is good at. Neither could do this protein alone. Together they can.

Hybrid classical-quantum is how real chemistry gets done in the near term, not pure quantum and not pure classical. Biochemistry is one of the applications pulling the field forward, especially structure-based drug design. And atom count is becoming the benchmark people compare against, the way transistor count once was for chips.